Penumbra (PEN) Revenue (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.76% |
| Dec 31, 2025 | 8.66% |
| Sep 30, 2025 | 4.49% |
| Jun 30, 2025 | 4.72% |
| Mar 31, 2025 | 2.73% |
| Dec 31, 2024 | 4.81% |
| Sep 30, 2024 | 0.55% |
| Jun 30, 2024 | 7.45% |
| Mar 31, 2024 | -2.12% |
| Dec 31, 2023 | 5.07% |
| Sep 30, 2023 | 3.61% |
| Jun 30, 2023 | 8.33% |
| Mar 31, 2023 | 9.12% |
| Dec 31, 2022 | 3.53% |
| Sep 30, 2022 | 2.56% |
| Jun 30, 2022 | 2.18% |
| Mar 31, 2022 | -0.06% |
| Dec 31, 2021 | 7.31% |
| Sep 30, 2021 | 3.18% |
| Jun 30, 2021 | 8.90% |
| Mar 31, 2021 | 1.38% |
| Dec 31, 2020 | 10.47% |
| Sep 30, 2020 | 43.73% |
| Jun 30, 2020 | -23.46% |
| Mar 31, 2020 | -5.46% |
| Dec 31, 2019 | 4.13% |
| Sep 30, 2019 | 3.95% |
| Jun 30, 2019 | 4.49% |
| Mar 31, 2019 | 6.33% |
| Dec 31, 2018 | 8.04% |
| Sep 30, 2018 | 1.98% |
| Jun 30, 2018 | 6.75% |
| Mar 31, 2018 | 6.92% |
| Dec 31, 2017 | 14.47% |
| Sep 30, 2017 | 4.12% |
| Jun 30, 2017 | 10.07% |
| Mar 31, 2017 | 0.15% |
| Dec 31, 2016 | 8.81% |
| Sep 30, 2016 | 3.20% |
| Jun 30, 2016 | 12.41% |
| Mar 31, 2016 | 6.44% |
| Dec 31, 2015 | 7.93% |
| Sep 30, 2015 | 19.16% |
| Jun 30, 2015 | 8.62% |
| Mar 31, 2015 | 10.02% |
| Dec 31, 2014 | 9.05% |
| Sep 30, 2014 | 3.13% |
| Jun 30, 2014 | 20.32% |